kaposi
sarcomaassoci
herpesviru
kshv
caus
kaposi
sarcoma
ks
lesser
extent
kshv
etiolog
associ
rare
neoplast
disord
like
primari
effus
lymphoma
pel
multicentr
castleman
diseas
mcd
ks
malign
vascular
tumor
character
lesion
occur
mainli
skin
also
affect
mucosa
viscer
hallmark
ks
angiogenesi
cell
prolifer
kshv
among
list
viral
pathogen
estim
caus
human
cancer
kshv
biphas
life
cycl
compris
latent
lytic
phase
replic
distinguish
base
diverg
gene
express
dynam
latent
lytic
phase
replic
allow
viru
persist
durat
host
notabl
kshv
establish
latenc
major
infect
given
instanc
subpopul
infect
cell
display
evid
lytic
gene
microrna
mirna
one
main
class
noncod
small
noncod
rna
regul
express
gene
human
genom
encod
thousand
late
mirna
emerg
pivot
compon
host
cell
respons
pathogen
includ
virus
bacteria
kshv
human
immunodefici
viru
epsteinbarr
viru
ebv
herp
simplex
viru
type
exampl
limit
number
virus
encod
kshv
encod
premirna
process
yield
matur
role
kshvencod
mirna
establish
andor
maintain
kshv
latenc
enhanc
angiogenesi
spread
infect
cell
interfer
host
immun
system
crucial
extens
work
conduct
kshv
encod
mirna
manner
kshv
replic
alter
cellular
howev
limit
work
along
line
understand
effect
cellular
mirna
respons
earli
stage
kshv
infect
cell
specif
intern
viru
recent
employ
deep
sequenc
first
time
analyz
mirna
express
profil
kshvinfect
bjab
cell
earli
stage
studi
attempt
deciph
cellular
alter
kshv
infect
physiolog
relev
cell
human
b
endotheli
cell
focus
express
effect
cellular
respons
kshv
infect
consist
elev
min
post
infect
pi
data
show
overexpress
cellular
inhibit
kshv
infect
cell
dampen
express
interferon
induc
transmembran
protein
interestingli
effect
close
relat
viru
epsteinbarr
viru
ebv
distant
rel
herp
simplex
follow
pattern
kshv
result
reveal
layer
common
theme
regul
host
cell
gene
mirna
intern
kshv
relat
virus
recent
conclud
studi
describ
signific
increas
express
host
cell
encod
earli
min
pi
present
studi
monitor
express
earli
time
point
kshv
infect
human
b
endotheli
cell
employ
human
b
bjab
endotheli
hmvecd
cell
physiolog
relev
cell
kshv
biolog
express
gradual
increas
min
pi
peak
min
pi
kshv
infect
bjab
fig
hmvecd
cell
fig
uninfect
bjab
hmvecd
cell
express
fig
b
express
known
mirna
significantli
alter
compar
earli
stage
kshv
infect
cell
fig
b
treatment
cell
unitsml
heparinas
iiii
h
prior
kshv
infect
cell
result
signific
drop
express
bjab
fig
hmvecd
cell
fig
also
infect
bjab
hmvecd
cell
uvkshv
could
induc
express
compar
level
wildtyp
kshv
fig
result
demonstr
kshv
induc
host
cell
earli
upon
infect
key
featur
novel
includ
secondari
structur
provid
tabl
supplement
fig
respect
evalu
biolog
effect
target
cell
analyz
effect
mimic
inhibitor
kshv
infect
rang
dose
test
studi
compar
report
earlier
dose
mimic
inhibitor
use
studi
significantli
induc
cell
death
bjab
hmvecd
cell
fig
b
transfect
bjab
fig
hmvecd
fig
cell
mimic
significantli
reduc
kshv
infect
cell
monitor
express
gene
earli
min
pi
kshv
entri
quick
process
ie
gene
express
immedi
upon
kshv
infect
significantli
alter
bjab
fig
hmvecd
fig
cell
either
transfect
scrambl
mirna
control
mirnc
mock
transfect
interestingli
effect
mimic
kshv
infect
bjab
hmvecd
cell
could
significantli
revers
cotransfect
cell
nm
inhibitor
fig
cotransfect
cell
mirn
alter
effect
mimic
fig
ascertain
effect
mimic
postbind
stage
infect
perform
bind
assay
bind
assay
perform
bjab
hmvecd
cell
demonstr
mimic
inhibitor
block
kshv
bind
target
cell
fig
incub
kshv
heparin
csa
significantli
block
kshv
bind
cell
fig
result
clearli
implic
inhibit
kshv
infect
cell
extend
understand
role
relat
virus
test
effect
mimic
inhibitor
ebv
infect
bjab
cell
interestingli
mimic
could
significantli
block
ebv
infect
bjab
cell
inhibit
could
specif
revers
mirinhibitor
fig
use
diana
mirmap
tool
algorithm
identifi
put
bind
site
locat
mrna
supplement
fig
confirm
abil
specif
inhibit
express
monitor
express
target
cell
untransfect
transfect
mimic
mirnc
prior
infect
transfect
bjab
hmvecd
cell
mimic
significantli
lower
express
min
pi
compar
untransfect
cell
cell
transfect
mirnc
fig
transfect
cell
mimic
could
specif
inhibit
express
min
till
h
pi
data
shown
result
authent
fact
express
may
well
regul
order
determin
bona
fide
target
luciferas
report
assay
perform
assay
two
quantifi
gene
encod
luciferas
protein
put
vector
utr
target
region
place
downstream
gluc
regul
translat
seap
place
regul
normal
cell
cotransfect
utr
vector
plasmid
mimic
mimic
significantli
decreas
rel
luciferas
activ
compar
cell
transfect
mirnc
fig
contrast
transfect
cell
mirinihibitor
revers
abil
mimic
lower
luciferas
activ
fig
invers
correl
observ
express
cours
kshv
infect
bjab
fig
hmvecd
fig
cell
result
suggest
directli
target
therebi
downregul
express
protein
express
significantli
elev
kshv
infect
bjab
hmvecd
cell
fig
express
increas
kshv
infect
cell
earli
min
pi
elev
min
min
pi
bjab
hmvecd
cell
respect
declin
sharpli
min
pi
fig
confirm
role
kshv
infect
target
cell
transient
transfect
bjab
hmvecd
cell
express
confirm
flow
cytometri
fig
kshv
infect
express
bjab
hmvecd
cell
measur
express
min
pi
idea
strictli
understand
effect
express
earli
stage
kshv
infect
bjab
fig
hmvecd
fig
cell
express
support
significantli
enhanc
kshv
infect
compar
cell
left
untransfect
mock
transfect
transfect
empti
vector
surprisingli
express
also
enhanc
ebv
infect
bjab
hmvecd
cell
fig
interestingli
cotransfect
cell
mimic
could
significantli
drop
kshv
infect
cell
compar
mirnc
fig
confirm
role
kshv
infect
cell
first
transfect
cell
sirna
specif
northern
blot
perform
hour
transfect
per
standard
protocol
monitor
mrna
express
fig
level
mrna
significantli
suppress
bjab
hmvecd
cell
sirna
compar
ns
sirna
control
fig
mrna
inhibit
observ
bjab
cell
hour
respect
sirna
transfect
fig
mrna
inhibit
observ
hmvecd
cell
hour
respect
sirna
transfect
express
level
significantli
alter
ns
sirna
control
cell
test
demonstr
specif
sirna
use
fig
express
target
cell
transfect
sirna
specif
significantli
lower
min
post
kshv
infect
fig
contrast
kshv
induc
express
untransfect
cell
transfect
ns
sirna
alter
fig
line
kshv
infect
cell
silenc
express
significantli
lower
compar
cell
untransfect
transfect
ns
sirna
fig
silenc
express
also
decreas
ebv
infect
cell
fig
viral
infect
monitor
perform
qrtpcr
taken
togeth
result
clearli
implic
role
enhanc
kshv
ebv
infect
cell
sinc
mirna
discoveri
year
ago
mirna
establish
key
player
molecular
mechan
mammalian
biolog
includ
mainten
normal
homeostasi
regul
diseas
pathogenesi
host
mirna
also
play
crucial
role
mount
immun
respons
microbi
infect
includ
caus
sever
virus
belong
herpesviru
polyomaviru
hepadnaviru
adenoviru
retroviru
encod
virusencod
mirna
vmirna
identifi
virusinfect
cell
significantli
influenc
viral
replic
diseas
progress
modul
viral
well
host
cellular
mrna
mani
cellular
mirna
affect
viral
replic
either
directli
bind
viral
genom
indirectli
target
host
factor
relat
sever
publish
work
describ
viru
cellular
encod
mirna
kshv
howev
date
report
role
cellular
mirna
earli
stage
kshv
infect
recent
studi
laboratori
use
combin
deep
sequenc
qrtpcr
identifi
cellular
activ
earli
min
current
studi
employ
physiolog
relev
human
b
cell
bjab
endotheli
cell
hmvecd
make
studi
meaning
kshv
biolog
accordingli
use
specif
primer
analyz
express
profil
cellular
first
min
kshv
infect
cell
success
viral
entri
measur
kshv
enter
cell
express
immedi
earli
gene
express
monitor
kshv
infect
bjab
hmvecd
cell
rapidli
trigger
express
earli
min
pi
peak
min
pi
fig
express
kshv
infect
bjab
higher
hmvec
cell
could
attribut
inherit
variat
observ
differ
cell
manner
respond
viru
moreov
express
level
mirna
shown
vari
among
tissu
cell
type
even
cell
cellular
trigger
uvkshv
infect
cell
treat
target
cell
heparinas
iiii
prior
infect
cell
wildtyp
kshv
fail
induc
express
treatment
cell
heparinas
iiii
cleav
heparan
sulfat
hs
differ
site
liber
cell
kshv
bind
target
cell
via
interact
hs
express
cell
taken
togeth
result
indic
follow
interact
viru
envelop
protein
host
cell
trigger
respons
ii
bind
kshv
cell
critic
express
cell
mimic
specif
inhibit
kshv
infect
bjab
hmvecd
cell
fig
transfect
cell
inhibitor
revers
effect
mimic
kshv
infect
cell
fig
effect
mimic
inhibitor
specif
scrambl
neg
control
mirnc
nonspecif
inhibitor
mirn
significantli
alter
kshv
infect
cell
fig
e
conclud
effect
mimic
inhibitor
kshv
infect
post
attach
stage
intern
advers
affect
viru
bind
cell
fig
studi
origin
want
use
two
relev
virus
neg
control
better
understand
specif
kshv
infect
cell
ebv
select
control
ebv
like
kshv
belong
belong
interestingli
observ
similar
effect
mimic
inhibitor
ebv
infect
cell
fig
could
due
fact
exhibit
share
common
threedimension
capsid
structur
along
fact
quit
bit
homolog
glycoprotein
express
viral
one
mirna
may
regul
mani
gene
target
one
gene
may
also
target
mani
accordingli
possibl
target
sever
gene
supplement
fig
use
bioinformat
tool
identifi
promis
target
ifitm
member
interferoninduc
amino
acid
protein
famili
includ
famili
protein
locat
chromosom
human
genom
origin
describ
highli
induc
gene
ifn
three
member
ifitm
protein
gain
promin
novel
antivir
ifnstimul
gene
isg
henc
set
test
effect
transfect
target
cell
gene
kshv
infect
target
cell
overexpress
significantli
enhanc
kshv
infect
cell
moder
enhanc
kshv
infect
alter
viral
infect
supplement
fig
base
result
focus
studi
term
earli
stage
kshv
infect
use
bioinformat
tool
determin
target
express
luciferas
assay
demonstr
abil
physic
interact
fig
mimic
specif
inhibit
express
could
revert
transfect
cell
inhibitor
fig
appar
invers
correl
observ
kshvinduc
express
respons
fig
propos
sharp
declin
express
min
pi
increas
express
fig
taken
togeth
studi
establish
direct
associ
virusinduc
endogen
express
biolog
kshv
express
mani
cell
type
includ
leukocyt
endotheli
modul
cell
function
includ
immunolog
respons
cell
prolifer
cell
adhes
germ
cell
ifitm
protein
significantli
upregul
interferon
type
ii
critic
antiviru
respons
innat
recent
report
indic
play
signific
role
viru
entri
inhibit
entri
mani
rna
virus
includ
influenza
viru
west
nile
viru
dengu
viru
hiv
suggest
mechan
ifitm
protein
restrict
viru
infect
includ
inhibit
viru
bind
correspond
cellular
receptor
inhibit
endocytosi
act
pattern
recognit
receptor
sens
viru
infect
activ
downstream
cellular
signal
protein
inhibit
fusion
viral
membran
cellular
endosom
vesicular
membran
block
creation
hemifus
reduc
membran
fluiditi
curvatur
possibl
disrupt
intracellular
cholesterol
howev
ifitm
also
enhanc
viral
infect
cell
modestli
enhanc
human
papillomaviru
infect
varieti
ii
zhao
et
al
shown
type
type
ii
significantli
promot
infect
human
coronaviru
induct
ifitm
protein
author
report
overexpress
significantli
increas
suscept
cell
gener
ifitm
famili
protein
affect
viru
entri
cell
overexpress
significantli
enhanc
kshv
infect
target
cell
fig
silenc
express
opposit
effect
fig
interestingli
observ
ident
effect
enhanc
ebv
infect
cell
fig
ifn
gener
consid
antivir
cytokin
inhibit
viru
infect
cell
stimul
fact
observ
signific
increas
express
earli
stage
kshv
infect
bjab
hmvecd
cell
supplement
fig
case
enhanc
infect
kshv
also
ebv
scenario
possibl
viru
infect
alter
ifn
associ
interestingli
enough
herpesvirus
group
includ
kshv
consid
rel
insensit
antivir
effect
ifn
varieti
differ
cell
way
result
demonstr
first
time
herpesvirus
kshv
ebv
hijack
benefit
facilit
viru
entri
cell
also
evad
ifninduc
antivir
effect
studi
provid
new
insight
viru
infect
kshv
includ
ebv
interact
target
cell
induc
within
minut
facilit
viru
entri
cell
kshvinduc
part
innat
immun
activ
system
occur
antigenindepend
reli
abil
host
recogn
viru
via
specif
pattern
recognit
counter
effect
kshvinduc
infect
cell
respond
within
short
period
time
induc
express
cellular
turn
inhibit
express
thu
limit
viru
infect
cell
perhap
could
mechan
superinfect
resist
sir
develop
cell
toward
kshv
relat
viral
pathogen
suppress
may
direct
indirect
effect
kshv
pathobiolog
directli
limit
kshv
infect
cell
ii
block
cell
therebi
promot
kshv
iii
reduc
virusinduc
inflamm
effect
biolog
kshv
better
understood
employ
threedimension
cell
cultur
model
mimic
certain
aspect
tissu
time
studi
viru
entri
alway
focus
primarili
role
viru
encod
glycoprotein
cognat
host
cell
receptor
knowledg
first
report
mirna
influenc
kshv
infect
cell
hope
open
door
understand
viru
entri
mirna
regul
gene
function
late
mirnabas
therapeut
use
effect
treat
autoimmun
cancer
includ
prostat
cancer
anim
model
fact
mirna
influenc
viru
entri
fascin
mirnabas
therapeut
like
use
mirmim
effect
use
treat
viru
entri
includ
pathogenesi
sever
question
need
answer
follow
enhanc
kshv
infect
cell
physic
bind
kshv
envelopeassoci
protein
facilit
endocytosi
ii
role
host
cell
receptor
viru
entri
iii
dynam
express
pattern
regul
kshv
infect
cell
iv
induct
kshv
infect
prevent
infect
cell
superinfect
kshv
relat
herpesvirus
vivo
current
studi
lab
dedic
answer
question
human
burkitt
lymphoma
b
cell
line
bjab
human
foreskin
fibroblast
hff
clonet
walkersvil
md
dermal
microvascular
endotheli
cell
hmvecd
clonet
use
studi
bjab
cell
propag
phenol
rpmi
medium
invitrogen
carlsbad
ca
hff
cell
cultur
dulbecco
modifi
eagl
medium
dmem
contain
charcoalstrip
fetal
bovin
serum
fb
atlanta
biolog
lawrencevil
ga
lglutamin
hmvecd
cell
propag
egm
mvmicrovascular
endotheli
cell
medium
clonet
per
standard
protocol
passag
number
hff
hmvecd
use
studi
rang
respect
cell
use
studi
neg
mycoplasma
test
mycoplasma
pcr
elisa
roch
life
scienc
cultur
condit
refer
supplement
data
virus
use
studi
wildtyp
herp
epsteinbarr
viru
ebv
gener
ultraviolet
uv
inactiv
kshv
uvkshv
per
earli
ldh
assay
perform
use
cytotox
nonradioact
kit
promega
per
earlier
target
cell
treat
differ
concentr
mimic
inhibitor
vbottom
plate
h
incub
cell
analyz
express
ldh
indic
cell
death
ldh
assay
perform
use
cytotox
nonradioact
kit
promega
per
earlier
sigmaaldridg
st
loui
mo
cytochalasin
sigmaaldridg
use
known
cell
death
induc
bjab
hff
hmvecd
cell
infect
multipl
infect
moi
kshv
ebv
cell
left
uninfect
infect
min
prior
wash
cell
twice
pb
process
appropri
rna
extract
total
rna
extract
use
trizol
invitrogen
carlsbad
ca
rna
concentr
measur
nanodrop
spectrophotomet
thermo
fisher
scientif
waltham
verifi
qualiti
use
agil
bioanalyz
agil
technolog
santa
clara
ca
rna
sampl
ratio
use
studi
extract
rna
use
synthes
cdna
express
monitor
qrtpcr
use
specif
primer
per
earlier
express
use
scale
measur
kshv
infect
cell
report
lowest
limit
detect
standard
sampl
copi
gene
result
use
primer
consist
confirm
monitor
express
anoth
viral
immedi
earli
ie
gene
vgpcr
data
shown
ebv
infect
monitor
use
specif
primer
homolog
kshv
ie
gene
target
cell
transient
transfect
plasmid
dna
use
fugen
hd
promega
madison
wi
per
manufactur
recommend
plasmid
pqcxip
encod
use
studi
kindli
gift
us
dr
michael
farzan
scripp
research
institut
jupit
usa
fugen
hddna
ratio
adher
cell
line
suspens
cell
line
use
transfect
target
cell
differ
concentr
mimic
scrambl
control
mirnc
mirna
inhibitor
nonspecif
ns
inhibitor
sigmaaldridg
achiev
use
fugen
hd
reagent
per
standard
laboratori
procedur
transient
transfect
experi
use
cell
conduct
h
post
transfect
effect
mirmim
inhibitor
kshv
bind
target
cell
assess
pcr
detect
cellbound
kshv
dna
briefli
untransfect
cell
cell
transfect
mirmim
inhibitor
infect
moi
kshv
min
incub
viru
cell
wash
three
time
pb
remov
unbound
viru
cell
pellet
total
dna
includ
repres
cell
bound
kshv
isol
use
dneasi
kit
qiagen
valencia
ca
subject
qpcr
analysi
monitor
accord
recent
publish
incub
kshv
heparin
chondroitin
sulfat
csa
sigmaaldridg
h
use
known
posit
neg
control
flow
cytometri
use
monitor
express
cell
per
earlier
briefli
target
cell
fix
ml
icecold
aceton
min
wash
thrice
pb
prior
incub
cell
rabbit
polyclon
antibodi
emd
millipor
billerica
min
cell
wash
thrice
pb
incub
fitc
conjug
appropri
secondari
igg
min
wash
analyz
facscan
flow
cytomet
becton
dickinson
appropri
gate
paramet
buffer
use
project
made
water
endotoxin
pyrogen
free
western
blot
conduct
per
earlier
use
follow
primari
antibodi
rabbit
polyclon
antibodi
emd
millipor
mous
antiactin
antibodi
clone
sigmaaldridg
qualiti
rna
test
use
spectrophotomet
rna
sampl
ratio
use
studi
approxim
ng
rna
revers
transcrib
reaction
volum
use
allinonetm
mirna
qrtpcr
detect
kit
genecopoeia
rockvil
md
briefli
cdna
synthes
reaction
mix
contain
reaction
buffer
poli
polymeras
rna
rtase
mix
reaction
perform
min
termin
min
cdna
produc
rt
reaction
dilut
tenfold
use
templat
pcr
reaction
appli
biosystem
viia
realtim
pcr
system
life
technolog
usa
system
rna
use
extern
refer
qualiti
extract
mirna
use
normal
express
level
mirna
measur
employ
qrtpcr
sybr
green
detect
specif
forward
primer
matur
mirna
sequenc
univers
adaptor
revers
primer
genecopoeia
usa
express
qrtpcr
conduct
per
earlier
use
appropri
luciferas
report
plasmid
wildtyp
purchas
genecopoeia
rockvil
md
cell
plate
onto
plate
h
postplat
cell
cotransfect
luciferas
report
plasmid
mimic
mirncna
scrambl
control
mirnc
use
fugen
hd
promega
h
post
transfect
supernat
collect
treatment
luciferas
activ
measur
use
secretepair
dual
luminesc
assay
kit
genecopoeia
per
manufactur
recommend
northern
blot
monitor
express
perform
use
dig
luminesc
detect
kit
roch
indianapoli
per
manufactur
express
inhibit
transfect
doublestrand
ds
rna
oligo
per
standard
sirna
purchas
dharmacon
rna
technolog
lafayett
co
briefli
cell
wash
twice
rpmi
incub
phenol
rpmi
supplement
fb
hour
incub
consid
h
experi
fig
target
cell
transfect
either
ds
short
interf
rna
sirna
nonspecif
ns
control
use
fugen
hd
per
manufactur
recommend
promega
hour
transfect
total
rna
isol
cell
subject
northern
blot
monitor
express
mrna
per
protocol
mention
materi
method
section
describ
northern
blot
anoth
set
experi
untransfect
cell
cell
transfect
sirna
ns
sirna
h
infect
moi
kshv
end
min
pi
kshv
infect
assess
monitor
express
qrtpcr
data
gener
analyz
studi
includ
publish
articl
supplementari
inform
file
